[HTML][HTML] Therapeutic options for COVID-19: a review
R Pujari, MV Thommana, BR Mercedes, A Serwat - Cureus, 2020 - ncbi.nlm.nih.gov
An acute respiratory disease caused by a novel coronavirus [severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …
An effective drug against COVID-19: reality or dream?
Introduction: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is well known
as a novel member of the coronavirus family which caused a sudden outbreak of …
as a novel member of the coronavirus family which caused a sudden outbreak of …
[HTML][HTML] COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs
A Bartoli, F Gabrielli, T Alicandro, F Nascimbeni… - Internal and emergency …, 2021 - Springer
Since its outbreak in China in December 2019 a novel Coronavirus, named SARS-CoV-2,
has spread worldwide causing many cases of severe pneumonia, referred to as COVID-19 …
has spread worldwide causing many cases of severe pneumonia, referred to as COVID-19 …
[HTML][HTML] Emerging treatment strategies for COVID-19 infection
M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
[HTML][HTML] Current status of COVID-19 treatment: An opinion review
The pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
has garnered the attention of scientists worldwide in the search for an effective treatment …
has garnered the attention of scientists worldwide in the search for an effective treatment …
[HTML][HTML] Pharmacological treatments of COVID-19
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …
which was reported for the first time in December 2019, was named by the World Health …
COVID-19: A review of the proposed pharmacological treatments
S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019
A Barlow, KM Landolf, B Barlow… - … : The Journal of …, 2020 - Wiley Online Library
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …
Updated approaches against SARS-CoV-2
H Li, Y Zhou, M Zhang, H Wang… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …
[HTML][HTML] Outbreak of COVID-19: An emerging global pandemic threat
M Peng - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Since the first outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection in Wuhan, Hubei, China in December 2019, it is now recognized as a pandemic by …
infection in Wuhan, Hubei, China in December 2019, it is now recognized as a pandemic by …